References
- Jensen C, Schiellerup P, Olsen K, Scheutz F, Petersen E, Gerner-Smidt P, et al. Antimicrobial treatment of asymptomatic carriers of verocytotoxin-producing Escherichia coli: an empiric study. Scand J Infect Dis 2005; 37: 61–3
- Belongia EA, Osterholm MT, Soler JT, Ammend DA, Braun JE, MacDonald KL. Transmission of Escherichia coli O157:H7 infection in Minnesota child day-care facilities. JAMA 1993; 269: 883–8
- Karch H, Russman H, Schnidt H, Schwarzkopf A, Heesmann J. Long-term shedding and clonal turnover of enterohemorrhagic Escherichia coli O157:H7 in diarrheal disease. J Clin Microbiol 1995; 33: 1602–65
- Shah S, Hoffman R, Shillam P, Wilson B. Prolonged feces shedding of Escherichia coli O157:H7 during an outbreak at a day-care center. Clin Infect Dis 1996; 23: 835–86
- Galanis E, Longmore K, Hasselback P, Swann D, Ellis A, Panaro L. Investigation of an E. coli O157:H7 outbreak in Brooks, Alberta, June–July 2002: the role of occult cases in the spread of infection within a day-care setting. Can Commun Dis Rep 2003; 29: 21–8
- Oai C H, Ahmed N, Lior H, Johnson WM, Sims HV, Wood DE. Epidemiology of sporadic diarrhea due to vancomycin-producing Escherichia coli; a 2-y prospective study. J Infect Dis 1988; 157: 1054–7
- Safdar N, Said A, Gangnon RE, Maki DG. Risk of hemolytic uremic syndrome after antibiotic therapy of Escherichia coli STEC:H7 enteritis: a meta-analysis. JAMA 2002; 288: 996–1001
- Enterohemorrhagic Escherichia coli infection in Japan as of April. IASR 2007;28:131–2.